Nurix Therapeutics to Participate in Upcoming Investor Conferences
SAN FRANCISCO, April 03, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein […]
Akoustis Introduces Two New 2.4 GHz BAW RF Filters for Wi-Fi Automotive and Access Point Applications
New High-Performance 2.4 GHz Channel 1-11 XBAW® Bandedge RF Filters for Improved Wi-Fi Range and Coexistence with LTE The A10124 […]
Himax to Unveil Revolutionary Ultralow Power Contactless Palm Vein Authentication Technology, WiseEye Vein, at ISC West
TAINAN, Taiwan, April 03, 2024 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX), an industry leader in fabless display driver […]
SANY Group and Ambarella Announce Strategic Cooperation to Accelerate Implementation of CV3-AD Domain Controller-Based Intelligent Driving Systems
CHANGSHA CITY, China and SANTA CLARA, Calif., April 03, 2024 (GLOBE NEWSWIRE) — SANY Group (SANY), a worldwide leader in […]
Pharming Group to participate in April investor conferences
Leiden, The Netherlands, April 3, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate […]
ObsEva Announces Delisting from SIX Swiss Exchange and Exemption from Certain Obligations Associated with the Maintenance of Listin
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – April 3, 2024 – […]
Announcement Execution of Memorandum of Understanding for Share Acquisition (Subsidiarization)
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (“we”, “our” or “us”) hereby announces that we […]
Heartland Express is recognized as one of Newsweek’s 2024 most trustworthy companies
NORTH LIBERTY, Iowa, April 02, 2024 (GLOBE NEWSWIRE) — Truckload carrier since 1978, Heartland Express continues a long-standing practice of […]
Business First Bancshares, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call
BATON ROUGE, La., April 02, 2024 (GLOBE NEWSWIRE) — Business First Bancshares, Inc. (Nasdaq: BFST), the parent company of b1BANK, […]
MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)
LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]
